A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Clinical trial NCT03257358 · COMPLETED
Trial details
- NCT number
- NCT03257358
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-19
- Primary completion
- 2019-03-05
- Enrollment
- 382
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.